Imaging cloak patent could enable more accurate 3D medical imaging
Winnipeg, MB – July 13, 2016 – Instead of a cloak of invisibility hiding a person in television and movies, a new method that describes mounting many imaging sensors underneath a flexible substrate could reveal tumors within humans or animals. Cubresa Inc., a medical imaging company that develops and markets nuclear imaging systems, today announced…
Preclinical PET Scanner for Simultaneous PET/MRI Adds to Cancer Research Arsenal at the University of Arizona
Cubresa’s NuPET™ scanner enables simultaneous preclinical molecular & functional imaging. The PET (Positron Emission Tomography) scanner inserts into existing MRI (Magnetic Resonance Imaging) systems and can speed drug development and clarify disease mechanisms for biomedical researchers. Cancer researchers can better understand tumors using Cubresa’s NuPET™ PET scanner with an MRI to see and measure responses…
Cubresa Featured in MTS Talks Business Hub Video
A new video on the MTS Talks website features Cubresa Founder and CTO James Schallenberg and CEO George Abe describe their work at Cubresa and their experience doing business in the Manitoba work environment, the healthcare industry and within a supportive community. They also offer some advice to aspiring entrepreneurs. MTS Talks says the two leaders “pack a punch in…
Cubresa Named in Globe & Mail Article on the Diverse, Strong Economy of Winnipeg
In a recent Globe & Mail article “Winnipeg: Canada’s unlikely economic sweet spot”, Cubresa is mentioned as part of an extremely diversified economy that powers the Manitoba provincial economy, an economy that no longer depends on a single natural resource. Cubresa board member, David Asper is quoted in the article. A lawyer and businessman, Asper plays a leading…
NuPET™ Preclinical PET Scanner Released for Simultaneous PET/MRI in Existing MRI Systems
Cubresa’s NuPET™ scanner enables simultaneous preclinical molecular & functional imaging. The PET (Positron Emission Tomography) scanner inserts into existing MRI (Magnetic Resonance Imaging) systems and can speed drug development and clarify disease mechanisms for biomedical researchers. Winnipeg, MB – April 26, 2016 – A compact PET scanner called NuPET™ has been commercially released for simultaneous preclinical…
ISMRM 24th Annual Meeting & Exposition
Cubresa Exhibited at the ISMRM 24th Annual Meeting & Exhibition in Singapore Thank you for visiting us in Booth 519 at the Suntec Convention & Exhibition Centre in Singapore, May 7 to 13, 2016 where we introduced our NuPET™ in-bore PET scanner for existing pre-clinical MRI systems. See our media release on the release of NuPET. Make an…
Cubresa Launches Simultaneous PET/MRI Technology
Empowering biomedical researchers with richer, more comprehensive imaging data to combat disease, Cubresa Inc. today announced its MR Compatible Small Animal PET Scanner.
April 7, 2015
State of Innovation Welcomes Cubresa Inc.
Cambridge MA – April 7, 2015 – To help researchers understand diseases that are difficult to diagnose like cancer and Alzheimer’s, an innovative Canadian preclinical imaging device company known as Cubresa has immersed itself in the intellectually-rich Massachusetts life sciences sector by opening the doors of its U.S. office in the Cambridge Innovation Center.
Cubresa to showcase its Spark preclinical SPECT scanner at WMIC
Winnipeg, Manitoba – July 21st, 2014 – Cubresa today announced it will exhibit its Spark compact SPECT scanner at the World Molecular Imaging Congress (WMIC), September 17th through September 20th in Seoul, Korea. Attendees are invited to visit the Cubresa booth (#413) in the exhibition hall to learn more.
Cubresa is a world leader in the design and development of clinical and preclinical PET inserts for MRI. Cubresa products enable medical professionals at leading universities, hospitals and pharmaceutical companies to visualize and measure biochemical processes at the molecular level.
Company
About Us
Leadership
Technology
Careers
Location
Cubresa Inc.
800-136 Market Ave
Winnipeg, MB, Canada
R3B 0P4
Products
Clinical:
Preclinical:
Contact
Request more information